KEVIN JOHNSON: Open Payments
NPI 1225336993 · GREENVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$551 in 27 payments from 9 companies in 2025. Trend: 2023 $726 · 2024 $615 · 2025 $551
Food & beverage: $551
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 12 | $230 |
| Melinta Therapeutics, LLC | 3 | $62 |
| Alexion Pharmaceuticals, Inc. | 2 | $52 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $46 |
| Janssen Biotech, Inc. | 2 | $45 |
| PFIZER INC. | 3 | $45 |
| ABBVIE INC. | 1 | $34 |
| BeOne Medicines USA, Inc. | 1 | $20 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
Products named: KEYTRUDA, Rezzayo, XIFAXAN, DARZALEX, VENCLEXTA, ZERBAXA, ULTOMIRIS, BRUKINSA.
Industry payments across NC — which companies pay providers there.
